Therapy-related myeloid leukemia following Pleuropulmonary blastoma: A case report
نویسندگان
1 Department of Pediatric Hematology and Oncology, Faculty of Medicine, Child Growth and Development Research Center and Isfahan Immunodefciency Research Center, Seyed Al-Shohada Hospital, Isfahan University of Medical Sciences, Isfahan, Iran.
2 Department of Pathology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
doi
10.18502/ijpho.v12i1.8365چکیده
The development of secondary malignancy (SM) is the most worrisome long-term complication of childhood cancer. Acute myeloid leukemia is the most prevalent neoplasm that occurs after treatment with alkylating agents and topoisomerase II inhibitors. Pleuropulmonary blastoma (PPB) is a rare lung neoplasm in children. Type II and type III of this ...
